
    
      Patients with abdominal cancer in active chemotherapeutic were allocated to either EPA in an
      oral nutritional drink (commercial) or capsules with fish oil. The dose of EPA was the same
      in both groups, and diets were adjusted as iso-caloric. Compliance to the fish oil treatment
      was the primary outcome. Blood concentrations of EPA secondary.
    
  